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CONRAD G. BRUNK, LAWRENCE HAWORTH & BRENDA
LEE, VALUE ASSUMPTIONS IN RISK ASSESSMENT: A CASE
STUDY OF THE ALACHLOR CONTROVERSY. (Wilfred Laurier

University Press 1991) [161 pp.] Glossary, notes. C91-094453-9; ISBN:
0-88920-200-1. [Cloth $US 35.00. Waterloo, Ontario, Canada N2L 3C5.I
In 1984, the Canadian Minister of Agriculture cancelled Monsanto's
registration of the herbicide, Alachlor. An appeal to a Review Board
resulted in a recommendation to the Minister for the reinstatement of
registration. Yet it went unheeded, and Alachlor remains unavailable in
Canada to this day. Brunk, Haworth and Lee examine the process
leading to the Board's recommendation and ask fundamental questions
regarding its risk assessment. They conclude that, despite predominance
of scientists on the Board and characterization of the process as
"scientific," the assessment heavily reflects value judgments of its
members.
Readers of RISK should be most interested in the authors' efforts to
peel open the classic risk-assessment model and show how such an
inquiry lends itself to an infusion of values. "What is at stake in this
debate," they say, "are conflicts among fundamental social and moral
values, which cannot be resolved by scientific inquiry alone." For
example, they cite the-Review Board's pervasive allusions to its belief
that the manufacturer of the sole competitive product would be left with
a monopoly and the effect this belief had on its recommendation.
Further, the authors argue that a vision of technology as the
indispensable problem-solver predisposed Board members to select
some and ignore other factors for their risk-benefit analysis. Thus,
economic gain from improved crop yields was chosen as the benefit to
be weighed against farmhand exposure to a potential carcinogen as the
risk. Other potential considerations, such as the risk of well-water
contamination were not considered, and the authors believe that this
could have been expected from an inquiry conducted only by scientists.
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The selection of factors for analysis and their ultimate weighing
necessarily turn on values for which the classic risk-assessment model
is ill-suited, warns VALUE ASSUMPTIONS.
The book is not without its shortcomings. Perhaps the most serious
is its failure to discuss the Pest Control Products Act of 1969 in more
than two small paragraphs. The book itself is quite value-laden in its
criticism of the Board's process, and lack of attention to the Board's
charter leaves one unsure that its process was other than one the
legislature dictated. If so, criticism of the Board is misdirected.
"Allow me to frame the issues, and I will control the outcome" is a
proposition the truth of which most lawyers quickly realize. In showing
how fundamental political, social and moral choices frame and dictate
the outcome of a seemingly value neutral process, Brunk, Haworth and
Lee make a strong case for wider recognition of the importance of issue
framing by scientists - particularly in situations where scientific
knowledge is being used to evaluate and manage risk.
Todd F. Volynt
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